1. P09 A Phase 2, randomized, double-blind study to evaluate the safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine (V116) in adults ≥50 years. (19th January 2023) Authors: Omole, Tosin; Cardona, Jose; Fraser, Neil J; Pagnussat, Sandra; Mularski, Richard; Andrews, Charles; Daboul, Nizar; Sapre, Aditi; Li, Jianing; Fernsler, Doreen; Xu, Weifeng; Gallagher, Nancy; Hall, Lori; Platt, Heather Journal: JAC-antimicrobial resistance Issue: Volume 5(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗